Trademarkia Logo

Australia

AU$
Trademark Search
X-CELLENT NATRILIX SR VERSUS CANDESARTAN AND AMLODIPINE IN THE, REDUCTION OF SYSTOLIC BLOOD PRESSURE IN HYPERTENSIVE PATIENTS

View On IPO.GOV.AU

X-CELLENT NATRILIX SR VERSUS CANDESARTAN AND AMLODIPINE IN THE, REDUCTION OF SYSTOLIC BLOOD PRESSURE IN HYPERTENSIVE PATIENTS
Not protected: Not accepted

Last updated on 9 Apr 2015

Owner Info

Biofarma

22 rue Garnier

F-92200 Neuilly-Sur-Seine, FRANCE

Serial Number

1033369 filed on 21 Sept 2004

Correspondent

Biofarma

22 rue Garnier,

F-92200 Neuilly-Sur-Seine,

FRANCE

X-CELLENT NATRILIX SR VERSUS CANDESARTAN AND AMLODIPINE IN THE, REDUCTION OF SYSTOLIC BLOOD PRESSURE IN HYPERTENSIVE PATIENTS

Classification Information

Class [005]
Pharmaceutical preparations for human use

Class [042]
Scientific research services for medical purposes, namely clinical studies in the field of hypertension

Class [044]
Consulting in the field of pharmacy; pharmaceutical or medical information services

Mark Details

Serial Number

1033369

Registered On

NA

Renewal On

NA

Mark Type

FANCY

Priority Claim (Convention Details)

Date

8 Apr 2004

Mark Type

FR

Legal History

Show more

Status DateAction Taken
9th Apr 2015General Correspondence (Application or Registration)
1st Dec 2011Amend Trade Mark Registration Particulars
18th May 2006IP Right Lapsed Published
8th May 2006Application Status
1st May 2006International Registration 16.5-Month Refusal Notice correspondence sent
18th Apr 2006Application Status
18th Jan 2005Adverse Report correspondence sent
18th Jan 2005Application Status
23rd Dec 2004IP Right Filed Published
14th Dec 2004Application Status